The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts. Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases. Scope • A snapshot of the global Market therapeutics scenario for Obsessive-Compulsive Disorder. • A review of the marketed products under prescription for Obsessive-Compulsive Disorder, regulatory information and marketing status. • Coverage of global patent coverage and detailed commentaries on the US patent challenges. • Graphical representation of investigational products for patent expiry and market exclusivities across the globe. • Product profiles for marketed products for Obsessive-Compulsive Disorder with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details. • Coverage of API Manufacturers for Obsessive-Compulsive Disorder drugs in the United States, Europe and Asian Regions with location details. • Coverage of Regulatory filings in the US, Europe, and Asia specifically India and China for Obsessive-Compulsive Disorder drugs. • Key discontinued Marketed products. • Global Sales Figure from 2012-2016.Reasons to Buy • Evaluate the marketing status and exclusivity details of Obsessive-Compulsive Disorder key products to exploit opportunities for generic drug development opportunities. • Key players in the pharmaceutical industry. •Strategic drivers and restraints of this market are revealed and market opportunities and challenges are identified. • Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Obsessive-Compulsive Disorder.